Financial Data and Key Metrics Changes - Net income per share was $0.09 on a fully diluted basis, and core FFO per share was $0.74, reflecting a 3% year-over-year increase [13] - Cash available for distribution was $29.3 million, exceeding consensus expectations for the quarter [13] - The company maintains its full year 2025 core FFO per share guidance in the range of $2.98 to $3.30 on a fully diluted basis [18] Business Line Data and Key Metrics Changes - The company advanced several key development projects backed by long-term non-cancelable leases, indicating a focus on disciplined growth [6][7] - Soft term lease exposure declined from 5.2% at year-end to 4.7%, demonstrating progress on renewals and tenant engagement [15] Market Data and Key Metrics Changes - The company is operating in a challenging market environment with elevated cost of capital, partly due to a recent dividend reset [9][17] - The company expects an additional $115 million in liquidity later this year from the FDA Atlanta lump sum repayment [16] Company Strategy and Development Direction - The company focuses on delivering reliable performance through mission-critical infrastructure and long-term leases [5][6] - The strategy emphasizes disciplined capital deployment and selective growth into high-quality assets that align with government missions [7][8] - The company aims to rebuild its shareholder base with long-term public investors who understand its mission and strategy [9] Management's Comments on Operating Environment and Future Outlook - Management noted that government real estate decisions are becoming more strategic and cost-conscious, positioning the company as a trusted partner [10] - The company is committed to executing its development pipeline with excellence and deepening relationships across federal, state, and local agencies [11] Other Important Information - The company has $122 million of revolver capacity available, maintaining a leverage ratio within the target range of 6.5 to 7.5 times [16][17] - The company is not pursuing growth for its own sake but is targeting opportunities that create durable value [18] Q&A Session Summary Question: Can you talk about your return expectations for the crime lab development project? - The development is expected to create about a 150 basis point spread to the cost of capital, consistent with other development growth targets [21] Question: What's the size of the pipeline of opportunities you're looking at? - The pipeline volume is estimated at $1 billion to $1.5 billion, with a focus on finding the best deals to meet growth goals [22]